Abstract
Background Oscillometry may be a feasible and sensitive tool for objective remote monitoring of paediatric asthma.
Methods School-aged cohorts of healthy, well controlled and poorly controlled asthma (defined as ≥2 exacerbations within the preceding 12m) performed daily home-based oscillometry for 3-4 months (C-100 tremoflo, Thorasys Ltd), alongside objective measures of asthma control (ACQ weekly, ACT monthly), medication use (Hailie®) and exacerbations.
Day-to-day variability was calculated as coefficient of variation (CV) for resistance at 5Hz (R5), reactance (X5) and Area under reactance curve (AX). We examined the ability to differentiate asthma from health and correlations with asthma control and exacerbation burden. Clinical exacerbation phenotypes were examined using principal component analysis and k-means clustering of oscillometry, symptoms, breathing parameters and symptoms.
Results Feasibility was 74.9 ± 16.0% in health (n=13, over 93.7 ± 16.2 days) and 80.6 ± 12.9% in asthma (n=42, over 101.6 ± 24.9 days; 17 well controlled 27 poor asthma control). Significantly higher day-to-day variability in all oscillometry indices occurred in asthma, vs. health, and with worsening asthma control. CV R5 when clinically stable (CV R5 stable) was the best discriminator of asthma from health (AUC 0.87, p=0.00001). CV R5 correlated with all measures of asthma control and asthma exacerbation burden, r 0.41-0.52 (all p<0.01). Two exacerbation phenotypes were found based on oscillometry data in the pre- exacerbation period, characterised by severity of impairment of R5, X5, AX and CV R5 (n=12 more severe). Findings were similar using post-exacerbation period oscillometry data (n=8 more severe). Symptoms did not differ across clusters.
Conclusions Home-based oscillometry monitoring was highly feasible over extended periods in school-aged asthmatics. Utility was evidenced by improved ability to differentiate asthma from health, reflect asthma control and exacerbation burden and phenotype exacerbations.
- It is highly feasible to perform daily parent-supervised FOT monitoring for extended periods up to 4 months duration in school-aged children
- In contrast to single-session based oscillometry indices, day-to-day variability in oscillometry indices were significantly higher in children with asthma compared to healthy controls, and differentiated levels of asthma control. The best performing parameter was CV R5.
- All day-to-day variability indices correlated with measures of asthma control, with the best performing parameter CV R5 during stable periods (i.e., not including exacerbation periods).
- Amongst asthmatics, day-to-day variability was greater during exacerbation periods than during non-exacerbation periods. Day-to-day variability correlated with measures of exacerbation burden, with the strongest correlations observed with CV R5 during stable periods
- Day-to-day variability identified two distinct clusters of exacerbation, which were not identified by conventional measures or symptom based assessment.
Conception and design: PDR, CT, GGK
Recruitment, acquisition, analysis and/or interpretation of data: JH, AW, KH, SP, EdQA, AB, PF, DF, GJ, CP, CT, GGK, PDR
Writing the manuscript or revising it critically: JH, AW, KH, SP, EdQA, AB, PF, DF, GJ, CP, HS, GGK, CT, PDR
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research study funding provided by the Sydney Medical School Foundation, the Ross Trust, and Asthma Australia.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The subjects presented in this manuscript were recruited across two studies, both with ethics approval from the Sydney Childrens Hospital Network (SCHN) Human Research Ethics Committee (14/SCHN/572 and 2019/ETH13753). Written informed consent/assent was obtained from all parents/guardians and children.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
